Advertisement
Screener

Carisma Therapeutics Inc. Net Income

Carisma Therapeutics Inc. Net Income

Carisma Therapeutics Inc. reported Net Income of $44.72 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2025-11-12

  • Carisma Therapeutics Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $44.72M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$9.77M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$9.27M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$17.64M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for fiscal 2024 was -$60.48M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for fiscal 2023 was -$86.88M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for fiscal 2022 was -$61.23M.
  • Carisma Therapeutics Inc. net income (loss) attributable to parent for fiscal 2021 was -$336.00K.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 9 month as first filedNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2025-09-30$44.72M
10-Q · filed 2025-11-12
$34.94M
derived: sum of 2 quarters · filed 2025-11-12
$25.68M
10-Q · filed 2025-11-12
$8.04M
derived: sum of 4 quarters · filed 2025-11-12
2025-06-30-$9.77M
10-Q · filed 2025-11-12
-$19.04M
10-Q · filed 2025-08-07
-$36.67M
derived: sum of 3 quarters · filed 2025-11-12
-$49.38M
derived: sum of 4 quarters · filed 2025-11-12
2025-03-31-$9.27M
10-Q · filed 2025-11-12
-$26.90M
derived: sum of 2 quarters · filed 2025-11-12
-$39.60M
derived: sum of 3 quarters · filed 2025-11-12
-$50.77M
derived: sum of 4 quarters · filed 2025-11-12
2024-12-31-$17.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$30.34M
derived: sum of 2 quarters · filed 2025-11-12
-$41.50M
derived: sum of 3 quarters · filed 2025-11-12
-$60.48M
10-K · filed 2025-03-31
2024-09-30-$12.70M
10-Q · filed 2025-11-12
-$23.86M
derived: sum of 2 quarters · filed 2025-11-12
-$42.84M
10-Q · filed 2025-11-12
-$63.80M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$11.16M
10-Q · filed 2025-11-12
-$30.14M
10-Q · filed 2025-08-07
-$51.10M
derived: sum of 3 quarters · filed 2025-11-12
-$72.50M
derived: sum of 4 quarters · filed 2025-11-12
2024-03-31-$18.98M
10-Q · filed 2025-11-12
-$39.94M
derived: sum of 2 quarters · filed 2025-11-12
-$61.34M
derived: sum of 3 quarters · filed 2025-11-12
-$81.22M
derived: sum of 4 quarters · filed 2025-11-12
2023-12-31-$20.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$42.36M
derived: sum of 2 quarters · filed 2025-03-31
-$62.24M
derived: sum of 3 quarters · filed 2025-03-31
-$86.88M
10-K · filed 2025-03-31
2023-09-30-$21.40M
10-Q · filed 2024-11-07
-$41.28M
derived: sum of 2 quarters · filed 2024-11-07
-$65.92M
10-Q · filed 2024-11-07
-$82.66M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$19.88M
10-Q · filed 2024-11-07
-$44.52M
10-Q · filed 2024-08-08
-$61.26M
derived: sum of 3 quarters · filed 2024-11-07
-$79.58M
derived: sum of 4 quarters · filed 2024-11-07
2023-03-31-$24.64M
10-Q · filed 2024-11-07
-$41.38M
derived: sum of 2 quarters · filed 2024-11-07
-$59.71M
derived: sum of 3 quarters · filed 2024-11-07
-$74.56M
derived: sum of 4 quarters · filed 2024-11-07
2022-12-31-$16.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$35.07M
derived: sum of 2 quarters · filed 2024-04-01
-$49.91M
derived: sum of 3 quarters · filed 2024-04-01
-$61.23M
10-K · filed 2024-04-01
-$19.88M
10-K · filed 2023-02-28
2022-09-30-$18.33M
10-Q · filed 2023-11-09
$20.46M
10-Q · filed 2022-11-07
-$33.17M
derived: sum of 2 quarters · filed 2023-11-09
-$44.49M
10-Q · filed 2023-11-09
-$12.31M
10-Q · filed 2022-11-07
-$35.54M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$14.85M
10-Q · filed 2023-08-10
-$31.96M
10-Q · filed 2022-08-08
-$26.16M
10-Q · filed 2023-08-10
-$32.77M
10-Q · filed 2022-08-08
-$17.22M
derived: sum of 3 quarters · filed 2023-08-10
$54.46M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$11.31M
10-Q · filed 2023-05-11
-$807.00K
10-Q · filed 2022-05-09
-$2.37M
derived: sum of 2 quarters · filed 2023-05-11
$69.31M
derived: sum of 3 quarters · filed 2023-05-11
$43.86M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$8.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$80.62M
derived: sum of 2 quarters · filed 2023-02-28
$55.18M
derived: sum of 3 quarters · filed 2023-02-28
-$336.00K
10-K · filed 2023-02-28
2021-09-30$71.67M
10-Q · filed 2022-11-07
$46.23M
derived: sum of 2 quarters · filed 2022-11-07
-$9.28M
10-Q · filed 2022-11-07
-$24.29M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$25.44M
10-Q · filed 2022-11-07
-$80.95M
10-Q/A · filed 2022-08-25
-$95.96M
derived: sum of 3 quarters · filed 2023-02-28
-$118.57M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$55.51M
10-Q · filed 2022-11-07
-$70.52M
derived: sum of 2 quarters · filed 2023-02-28
-$93.13M
derived: sum of 3 quarters · filed 2023-02-28
-$119.47M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$15.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$37.62M
derived: sum of 2 quarters · filed 2023-02-28
-$63.96M
derived: sum of 3 quarters · filed 2023-02-28
-$22.40M
10-K · filed 2023-02-28
2020-09-30-$22.61M
10-Q · filed 2021-11-08
-$48.95M
derived: sum of 2 quarters · filed 2021-11-08
-$7.39M
10-Q · filed 2021-11-08
-$40.94M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30-$26.34M
10-Q · filed 2021-11-08
$15.22M
10-Q · filed 2021-08-09
-$18.33M
derived: sum of 3 quarters · filed 2021-11-08
-$31.46M
derived: sum of 4 quarters · filed 2021-11-08
2020-03-31$41.56M
10-Q · filed 2021-11-08
$8.01M
derived: sum of 2 quarters · filed 2021-11-08
-$5.12M
derived: sum of 3 quarters · filed 2021-11-08
-$59.46M
derived: sum of 4 quarters · filed 2021-11-08
2019-12-31-$33.55M
10-K · filed 2020-03-16
-$46.69M
derived: sum of 2 quarters · filed 2020-11-09
-$101.02M
derived: sum of 3 quarters · filed 2020-11-09
-$107.50M
10-K · filed 2022-02-28
2019-09-30-$13.13M
10-Q · filed 2020-11-09
-$67.47M
derived: sum of 2 quarters · filed 2020-11-09
-$73.95M
10-Q · filed 2020-11-09
-$80.70M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$54.34M
10-Q · filed 2020-11-09
-$60.81M
10-Q · filed 2020-08-10
-$67.57M
derived: sum of 3 quarters · filed 2020-11-09
-$81.59M
derived: sum of 4 quarters · filed 2020-11-09
2019-03-31-$6.48M
10-Q · filed 2020-11-09
-$13.24M
derived: sum of 2 quarters · filed 2020-11-09
-$27.25M
derived: sum of 3 quarters · filed 2020-11-09
-$36.21M
derived: sum of 4 quarters · filed 2020-11-09
2018-12-31-$6.76M
10-K · filed 2020-03-16
-$20.77M
derived: sum of 2 quarters · filed 2020-03-16
-$29.73M
derived: sum of 3 quarters · filed 2020-03-16
-$33.69M
10-K · filed 2021-03-15
2018-09-30-$14.02M
10-K · filed 2020-03-16
-$22.97M
derived: sum of 2 quarters · filed 2020-03-16
-$26.94M
10-Q · filed 2019-11-12
-$33.48M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$8.96M
10-K · filed 2020-03-16
-$12.92M
10-Q · filed 2019-08-08
-$19.47M
derived: sum of 3 quarters · filed 2020-03-16
-$28.57M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$3.96M
10-K · filed 2020-03-16
-$10.51M
derived: sum of 2 quarters · filed 2020-03-16
-$19.61M
derived: sum of 3 quarters · filed 2020-03-16
-$26.93M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31-$6.55M
10-K · filed 2019-03-01
-$15.65M
derived: sum of 2 quarters · filed 2019-03-01
-$22.97M
derived: sum of 3 quarters · filed 2019-03-01
-$29.03M
10-K · filed 2020-03-16
2017-09-30-$9.11M
10-K · filed 2019-03-01
-$16.42M
derived: sum of 2 quarters · filed 2019-03-01
-$22.48M
10-Q · filed 2018-11-09
-$26.01M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$7.32M
10-K · filed 2019-03-01
-$13.38M
10-Q · filed 2018-08-14
-$16.91M
derived: sum of 3 quarters · filed 2019-03-01
$2.58M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$6.06M
10-K · filed 2019-03-01
-$9.59M
derived: sum of 2 quarters · filed 2019-03-01
$9.89M
derived: sum of 3 quarters · filed 2019-03-01
$3.40M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$3.53M
10-K · filed 2018-04-02
$15.96M
derived: sum of 2 quarters · filed 2018-04-02
$9.46M
derived: sum of 3 quarters · filed 2018-04-02
$1.89M
10-K · filed 2019-03-01
2016-09-30$19.49M
10-K · filed 2018-04-02
$13.00M
derived: sum of 2 quarters · filed 2018-04-02
$5.42M
10-Q · filed 2017-11-17
-$4.91M
derived: sum of 4 quarters · filed 2018-04-02
2016-06-30-$6.49M
10-K · filed 2018-04-02
-$14.06M
10-Q · filed 2017-08-14
-$24.39M
derived: sum of 3 quarters · filed 2018-04-02
-$34.09M
derived: sum of 4 quarters · filed 2018-04-02
2016-03-31-$7.57M
10-K · filed 2018-04-02
-$17.90M
derived: sum of 2 quarters · filed 2018-04-02
-$27.60M
derived: sum of 3 quarters · filed 2018-04-02
-$34.50M
derived: sum of 4 quarters · filed 2018-04-02
2015-12-31-$10.33M
10-K · filed 2017-03-24
-$20.02M
derived: sum of 2 quarters · filed 2017-03-24
-$26.93M
derived: sum of 3 quarters · filed 2017-03-24
-$33.45M
10-K · filed 2018-04-02
2015-09-30-$9.69M
10-K · filed 2017-03-24
-$16.60M
derived: sum of 2 quarters · filed 2017-03-24
-$23.12M
10-Q · filed 2016-11-14
-$31.26M
derived: sum of 4 quarters · filed 2017-03-24
2015-06-30-$6.91M
10-K · filed 2017-03-24
-$13.43M
10-Q · filed 2016-08-12
-$21.57M
derived: sum of 3 quarters · filed 2017-03-24
-$32.24M
derived: sum of 4 quarters · filed 2017-03-24
2015-03-31-$6.52M
10-K · filed 2017-03-24
-$14.66M
derived: sum of 2 quarters · filed 2017-03-24
-$25.34M
derived: sum of 3 quarters · filed 2017-03-24
-$33.46M
derived: sum of 4 quarters · filed 2017-03-24
2014-12-31-$8.14M
10-K · filed 2016-03-25
-$18.81M
derived: sum of 2 quarters · filed 2016-03-25
-$26.93M
derived: sum of 3 quarters · filed 2016-03-25
-$34.16M
10-K · filed 2017-03-24
2014-09-30-$10.67M
10-K · filed 2016-03-25
-$18.80M
derived: sum of 2 quarters · filed 2016-03-25
-$26.02M
10-Q · filed 2015-11-04
-$31.08M
derived: sum of 4 quarters · filed 2016-03-25
2014-06-30-$8.12M
10-K · filed 2016-03-25
-$15.34M
10-Q · filed 2015-08-13
-$20.41M
derived: sum of 3 quarters · filed 2016-03-25
-$24.22M
derived: sum of 4 quarters · filed 2016-03-25
2014-03-31-$7.22M
10-K · filed 2016-03-25
-$12.29M
derived: sum of 2 quarters · filed 2016-03-25
-$16.10M
derived: sum of 3 quarters · filed 2016-03-25
-$19.73M
derived: sum of 4 quarters · filed 2016-03-25
2013-12-31-$5.07M
10-K · filed 2015-03-06
-$8.88M
derived: sum of 2 quarters · filed 2015-03-06
-$12.51M
derived: sum of 3 quarters · filed 2015-03-06
-$18.02M
10-K · filed 2016-03-25
2013-09-30-$3.81M
10-K · filed 2015-03-06
-$7.45M
derived: sum of 2 quarters · filed 2015-03-06
-$12.96M
10-Q · filed 2014-11-13
2013-06-30-$3.63M
10-K · filed 2015-03-06
-$9.15M
10-Q · filed 2014-08-13
2013-03-31-$5.51M
10-K · filed 2015-03-06
2012-12-31-$19.66M
10-K · filed 2015-03-06